The Use of Smallpox vaccine for Monkeypox..!?
The european Commission has approved the smallpox vaccine for use in monkey measles. Worldwide, monkeypox has infected nearly 16,000 people in 72 countries. Following this, the World health Organization (WHO) declared the disease a public emergency. The european Commission has approved the use of the smallpox vaccine in monkey measles by EU countries.
It has been reported that a vaccine produced by a Danish pharmaceutical company can protect against monkeypox. Since 2013, the Imvanex vaccine has been used as a smallpox vaccine by the european Union.
It is now approved for use in both monkeypox and smallpox. It has been reported that there are common characteristics between these two disease-causing viruses.
The initial symptoms of monkey measles are fever, headache, muscle aches, and backaches that last for five days. Also, there will be sores on the body, spots, and sores on the data-face, hands, legs, etc. people should be careful because people who are in close contact with monkeypox sufferers and those who share things with them can get infected.
Outsiders should clean the areas after coming and going, wear data-face masks and avoid close contact with people suffering from monkeypox.